Introduction
============

Esophageal squamous cell carcinoma carries a poor prognosis in symptomatic patients because of late diagnosis and the technical difficulty of surgical resection in patients with locally advanced disease. The median survival in those with advanced disease is less than a year [@JR167-1]. In contrast, the 5-year survival rate in asymptomatic patients with stage 0 exceeds 95 % [@JR167-1].

Patients with head and neck cancer have a risk of developing second primary esophageal squamous cell carcinoma with an incidence of 9 -- 44 % [@JR167-1] [@JR167-2] [@JR167-3] [@JR167-4] [@JR167-5] [@JR167-6] [@JR167-7] [@JR167-8] [@JR167-9] [@JR167-10]. The detection of early esophageal squamous cell neoplasms (ESCN) improves the survival rate [@JR167-11] [@JR167-12]. Moreover, these ESCNs can be resected by endoscopy techniques such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) [@JR167-2] [@JR167-13] [@JR167-14] [@JR167-15]. Therefore, patients with head and neck cancer are recommended to have a surveillance endoscopy for second primary ESCN [@JR167-13] [@JR167-16].

Lugol's chromoendoscopy, with an excellent sensitivity (100 %), has been widely used in a protocol for ESCN surveillance [@JR167-17] [@JR167-18]. Lugol's voiding lesions larger than 5 mm have been reported to be associated with dysplastic change [@JR167-17] [@JR167-18]. However, the specificity of Lugol's chromoendoscopy is considered suboptimal (63 -- 85 %), as many non-neoplastic lesions, such as atrophic change and esophagitis, also appeared unstained by Lugol's solution [@JR167-19] [@JR167-20] [@JR167-21] [@JR167-22].

Probe-based confocal laser endomicroscopy (pCLE), allowing real-time histological analysis [@JR167-23] [@JR167-24] [@JR167-25], and dual focus narrow-band imaging (dNBI) evaluation of vascular networks for the possibility of detecting malignancy, can be adopted to characterize and predict the malignancy of Lugol's voiding lesions [@JR167-20] [@JR167-21].

To date, there has been no direct comparison between the two modalities in patients with high risk for ESCN undergoing endoscopic surveillance with Lugol's chromoendoscopy. The objective of this study was to compare the diagnostic value of pCLE and dNBI for ESCN diagnosis in patients with a history of previous head and neck squamous cell carcinomas undergoing endoscopic surveillance. All Lugol's voiding lesions larger than 5 mm were targeted and characterized by these two endoscopic real-time histological readings.

Material and methods
====================

Patients
--------

This study was conducted at the King Chulalongkorn Memorial Hospital, Bangkok from March 2013 to June 2014. Patients over 18 years of age with a histologically confirmed diagnosis of head and neck cancer diagnosed during the period 1 January 2003 to 31 December 2012, at the King Chulalongkorn Memorial Hospital without dysphagia were recruited. Patients' contact information was obtained from the hospital database. Patients with squamous cell cancer of the nasopharynx were excluded because of its poor correlation with a second primary ESCN [@JR167-6]. Other exclusion criteria were a history of esophageal surgery, esophageal stricture or obstruction, esophageal varices, known cases of esophageal cancer, uncorrectable coagulopathy and thrombocytopenia, pregnancy, thyrotoxicosis, creatinine clearance less than 30 mL/min, and history of allergy to iodine or fluorescein. The research protocol was approved by the hospital ethical committee and informed consent was given by all patients (NCT02182804).

Study design
------------

This study was a single-center, nonrandomized, cross-sectional trial on the discrimination performance of dNBI and pCLE for ESCN diagnosis in Lugol's voiding lesions. The Lugol's voiding lesions were examined by dNBI first and, subsequently, by pCLE without randomized crossover because the pCLE technique requires direct contact between the mucosa and the pCLE probe, which could alter the interpretation of intrapapillary capillary loops (IPCLs) by dNBI. Therefore, pCLE could not be performed first.

Sample size calculation and statistical analysis
------------------------------------------------

The sample size of this pilot study was calculated based on a confidence interval (CI) approach using a formula for 95 %CI for a single proportion [@JR167-26]: p ± 1.96 √\[p(1 -- p)/n\] where "p" is the anticipated value of specificity and "n" is the sample size. The anticipated value of specificity was obtained from the results of previous studies with endoscope-based confocal laser endomicroscopy (eCLE) [@JR167-25] and dNBI [@JR167-20] for the screening of esophageal cancer in patients with primary head and neck cancers. To estimate the specificity of pCLE of 95 % to be within a 95 % confidence interval of ±9 % and the specificity of dNBI of 80 % to be within a 95 % confidence interval of ±17 %, the calculated sample size for the number of lesions would be 21 lesions. For sample size estimation for number of patients, we inserted an alpha probability of 0.05, power 0.8, sensitivity of first test 0.95, and sensitivity of second test 0.8, and a minimum of 40 patients was required.

The baseline descriptive data for the patients were analyzed by means and standard deviations for continuous variables, and by percentage and frequency for categorical variables. All of the endoscopic evaluations from both dNBI and pCLE were compared with the matched histology. By using histology as the gold standard, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of dBNI and pCLE diagnoses on Lugol's voiding lesions were calculated. The difference of these parameters for dNBI vs. pCLE was compared using McNemar's test. *P* values less than 0.05 were considered to be statistically significant. We assumed that the pathology of each lesion in the same patient with multiple lesions was independent, and that the evaluation from dNBI was also independent of the subsequent evaluation from pCLE. Ninety-five percent confidence intervals for sensitivity, specificity, PPV, NPV, and accuracy were calculated using the normal approximation interval. Statistical analyses were performed using IBM SPSS software version 17.0 for Windows (IBM Corp., United States).

Instrument and criteria to diagnose ESCN
----------------------------------------

All examinations were performed using the GIF-HQ190 EVIS EXERA III gastrointestinal videoscope (Olympus, Tokyo, Japan) with dual focus two-stage optical lens technology (45 × optical magnification, 75 × with additional digital magnification) allowing a detailed study of esophageal IPCLs, and the Cellvizio gastroflex (Mauna Kea Technology, Paris, France) with 1000 × magnification provided in vivo black and white histological images.

Since all esophageal lesions had already been identified by Lugol's staining, the purpose of dNBI examination was only to characterize the Lugol's voiding lesions and not to detect additional lesions. According to Inoue's classification using NBI with "magnification" as a modality to diagnose ESCN [@JR167-27], mucosa containing regular IPCLs was considered normal epithelium ([Fig. 1 a](#FI167-1){ref-type="fig"}). In contrast, mucosa containing dilatation, tortuosity, caliber change, and variation in shape of the IPCLs was considered neoplastic. In the present study, all Lugol's voiding lesions with two or more of the described abnormal IPCL patterns were considered ESCNs ([Fig. 1 b](#FI167-1){ref-type="fig"}).

![Dual focus narrow-band imaging (dNBI) shows the regular intrapapillary capillary loops (IPCLs) in the normal esophageal epithelium. **b** Dual focus narrow-band imaging (dNBI) shows the dilatation, tortuousity, caliber change, and variation in shape of the IPCLs in the early esophageal squamous cell neoplasm (ESCN).](10-1055-s-0034-1391903-i167ei1){#FI167-1}

The pCLE interpretation was based on cellular and vascular criteria. As there were no previous criteria to diagnose ESCN by pCLE, we adopted the criteria from the previous study using eCLE. However, we accepted that there is a certain difference in scanning depth between pCLE and eCLE as pCLE provides a fixed scanning depth of 55 -- 65 µm, whereas eCLE provides a wider range of adjustable scanning depth (0 -- 250 µm). For cellular criteria, normal squamous epithelial cells were homogenous with regular architecture and clearly visible borders of the squamous cells ([Fig. 2 a](#FI167-2){ref-type="fig"}). In contrast, the neoplastic epithelium was inhomogeneous with irregular architecture of the squamous cells. In the majority of cases, these cells displayed no clearly visible border between the cells ([Fig. 2 b](#FI167-2){ref-type="fig"}). For vascular criteria, normal capillaries appeared regular without fluorescein leakage ([Fig. 3 a](#FI167-3){ref-type="fig"}), whereas neoplastic capillaries were irregular, twisted, dilated, and elongated ([Fig. 3 b](#FI167-3){ref-type="fig"}). Occasionally, fluorescein leakage ([Fig. 3 b](#FI167-3){ref-type="fig"} (arrow)) could also be observed [@JR167-17].

![Probe-based confocal laser endomicroscopy (pCLE) shows the homogenous squamous epithelial cells with regular architecture and clearly visible borders. **b** Probe-based confocal laser endomicroscopy (pCLE) shows the inhomogeneous squamous epithelium with irregular architecture and without clearly visible borders between cells in the early esophageal squamous cell neoplasm (ESCN).](10-1055-s-0034-1391903-i167ei2){#FI167-2}

![Probe-based confocal laser endomicroscopy (pCLE) shows the regular capillary without fluorescein leakage. **b** Probe-based confocal laser endomicroscopy (pCLE) shows the irregular, twisted, dilated, and elongated capillary in the neoplastic lesion. Fluorescein leakage could also be observed (arrow).](10-1055-s-0034-1391903-i167ei3){#FI167-3}

Procedure
---------

The procedures were performed under conscious sedation with meperidine and midazolam with an additional 10 % lidocaine oral spray. The level of sedation was targeted at moderate to deep sedation in order to obtain satisfactory pCLE images. Propofol was not used for sedation in this study. Initially, standard white light upper endoscopy (WLE) was performed. When lesions, such as demarcated red lesions, elevated or depressed lesions [@JR167-20], were detected, the size and location, and an image of each of these lesions were recorded as abnormal areas detected by WLE. These findings were later compared and mapped with the subsequent Lugol's voiding lesions. Next, a 0.5 % Lugol's solution was sprayed onto the esophageal mucosa starting from the esophagogastric junction to just below the upper esophageal sphincter (approximately 15 cm from the incisor) [@JR167-25]. Under WLE, we recorded the size, location, and images of all of the Lugol's voiding lesions larger than 5 mm. The widest dimension of the Lugol's voiding lesion was determined by comparing with a 5-mm forceps. The locations of Lugol's voiding lesions were mapped by the distance from the incisor and the relative position to the scope. After having heavily irrigated the mucosa with normal saline, dNBI was used to evaluate the IPCL pattern of the Lugol's voiding lesions by the first endoscopist (PP), who had extensive experience (\> 100 procedures over a number of years) of performing dNBI examinations in many gastrointestinal structures, including esophageal squamous cell carcinoma, before entering this study.

To avoid a carry-over effect, the lesion was then examined with pCLE by an independent endoscopist (RP) who was blinded to the dNBI result and was called in only after the first endoscopist had finished the dNBI examination and the endoscope had been switched back to white light mode. The endoscopist performing pCLE was also experienced (\> 100 procedures) and had performed pCLE examinations in many gastrointestinal structures including the esophagus, stomach, and duodenum. However, experience with pCLE for ESCN detection might be at a fundamental stage as this was a pilot study. Although we did not have an objective measurement, we believed that the two endoscopists had comparable experience in diagnosing esophageal squamous cell carcinoma. After intravenously injecting 5 mL of 10 % fluorescein sodium for 30 seconds, the process to characterize Lugol's voiding lesions was carried out. When there was more than one Lugol's voiding lesion during a single examination, tandem examinations by dNBI and pCLE were performed lesion by lesion from the distal esophagus upwards. We selected up to five lesions per patient for study and this was still manageable without any confusion in tracking the lesions. The distal tip of the endoscope was fixed on the target Lugol's voiding lesion while the two endoscopists swapped over. Irrigation with saline was used only at that target lesion. After switching endoscopist, additional Lugol's solution spray was used if required.

Finally, all Lugol's voiding lesions larger than 5 mm were biopsied by the endoscopist performing the pCLE. Mucosal low grade intraepithelial neoplasias and high grade intraepithelial neoplasias, as defined by the revised Vienna classification [@JR167-28], were used to diagnose ESCNs in the present study. All histologic examinations were performed by an experienced pathologist (NW) who was blinded to the endoscopic results.

Results
=======

There were 631 patients with a previous history of head and neck cancer in the 10-year record. Three attempts were made to contact the patients through all available phone numbers before considering as failure to contact. Of the 631 patients, 587 were excluded for the following reasons: patients could not be contacted (n = 458), death (n = 72), esophageal obstruction or stricture, previous esophageal surgery (n = 34), and patients who refused to participate (n = 23). Finally, 44 asymptomatic patients with a previous history of head and neck cancer were eligible for the study as shown in [Fig. 4](#FI167-4){ref-type="fig"}. Demographic and index head and neck cancer data are shown in [Table 1](#TB167-1){ref-type="table"}. The majority (86 %) of patients were male with a mean age of 60 years (range 23 -- 77 years). In total, 27 patients (62 %) were ex-smokers, 12 patients (27 %) never smoked, and 5 patients (11 %) were current smokers; 17 patients (39 %) were ex-drinkers, 16 patients (36 %) never drank, and 11 patients (25 %) were current drinkers. Based on the hospital records, the demographic data for excluded patients were not grossly different from that for recruited patients (data not shown).

![ Diagram of the study population.](10-1055-s-0034-1391903-i167ei4){#FI167-4}

###### Characteristics of the enrolled patients (n = 44).

  -------------------------------------- ----------------------------
  Gender                                 
   Male, n (%)                           38 (86)
   Female, n (%)                          6 (14)
  Age, years                             60 (range 23 -- 77, SD 12)
  Index head and neck cancer             
   Glottis, n (%)                        14 (32)
   Oral cavity, n (%)                     9 (20)
   Tonsil, n (%)                          8 (18)
   Hypopharynx, n (%)                     6 (14)
   Tongue, n (%)                          5 (11)
   Oropharynx, n (%)                      2 (5)
  Treatment status                       
   Cured with regular follow-up, n (%)   38 (86)
   Under ongoing treatment, n (%)         4 (9)
   Cured with no follow-up, n (%)         2 (5)
  -------------------------------------- ----------------------------

The endoscopic diagnoses under WLE are shown in [Table 2](#TB167-2){ref-type="table"}. One patient developed bleeding after biopsy and was successfully treated with endoscopic clipping.

###### Characteristics of 21 biopsied Lugol's voiding lesions among patients with head and neck cancers.

  Case   Age   Sex   Location of head and neck carcinoma   Location   WLE        IPCL pattern on dNBI   Cellular findings on pCLE                                                   Vascular findings on pCLE           Histology
  ------ ----- ----- ------------------------------------- ---------- ---------- ---------------------- --------------------------------------------------------------------------- ----------------------------------- -----------------------------
   1     58    M     Hypopharynx                           Middle     Missed     III                    Homogeneous, regular architecture, clearly visible border                   Regular                             Active esophagitis
   2     70    M     Glottis                               Middle     Missed     III                    Homogeneous, regular architecture, clearly visible border                   Regular                             Glycogenation/inflammation
                     Glottis                               Middle     Missed     III                    Homogeneous, regular architecture, clearly visible border                   Regular                             Glycogenation/inflammation
                     Glottis                               Upper      Missed     III                    Homogeneous, regular architecture, clearly visible border                   Regular                             Glycogenation/ inflammation
   3     71    M     Hypopharynx                           Middle     Missed     III                    Homogeneous, regular architecture, clearly visible border                   Elongated                           Unremarkable change
   4     66    F     Oropharynx                            Middle     Missed     IV                     Inhomogeneous, irregular architecture, blurry border, dark cells            Irregular, elongated and dilated    HGD
   5     60    M     Oral cavity                           Upper      Detected   IV                     Inhomogeneous, irregular architecture, blurry border                        Elongated and dilated               Active esophagitis
                                                           Upper      Detected   IV                     Inhomogeneous, irregular architecture, blurry border                        Irregular, elongated, and dilated   Active esophagitis
                                                           Middle     Detected   IV                     Inhomogeneous, irregular architecture, blurry border                        Irregular and dilated               Active esophagitis
                                                           Middle     Detected   IV                     Inhomogeneous, irregular architecture, blurry border, dark cells            Irregular                           Active ulcer
                                                           Lower      Detected   IV                     Homogeneous, regular architecture, clearly visible border, dark cells       Irregular, elongated, and dilated   HGD
   6     58    M     Oral cavity                           Upper      Detected   III                    Homogeneous, regular architecture, clearly visible border, columnar cells   Regular                             Inlet patch
   7     60    M     Glottic                               Lower      Missed     III                    Homogeneous (poor image quality)                                            Dilated                             LGD
   8     63    M     Supraglottic                          Middle     Detected   IV                     Inhomogeneous, irregular architecture, blurry border, dark cells            Irregular, elongated and dilated    LGD
                                                           Middle     Detected   IV                     Inhomogeneous, irregular architecture, blurry border, dark cells            Irregular, elongated and dilated    HGD
                                                           Lower      Missed     IV                     Homogeneous, irregular architecture, blurry border, dark cells              Irregular                           LGD
                                                           Lower      Missed     IV                     Homogeneous, irregular architecture, clearly visible border                 Irregular, elongated and dilated    Unremarkable change
   9     59    M     Pyriform                              Middle     Missed     IV                     Inhomogeneous, irregular architecture, blurry border, dark cells            Irregular, elongated                HGD
  10     65    M     Hard palate                           Lower      Missed     III                    Inhomogeneous, irregular architecture, blurry border, dark cells            Regular                             Active esophagitis
  11     64    M     Oropharynx                            Lower      Missed     N/A                    Homogeneous (poor image quality)                                            Regular (poor image quality)        Unremarkable change
  12     73    M     Tonsil                                Lower      Missed     III                    Homogeneous, irregular architecture, clearly visible border                 Regular                             Active esophagitis

WLE, white light endoscopy; IPCL, intrapapillary capillary loop; dNBI, dual focus narrow-band imaging; pCLE, probed-based confocal laser endomicroscopy; HGD, high grade dysplasia; LGD, low grade dysplasia.

WLE was able to detect eight lesions in three patients, of which five were elevated lesions and the other three were flat demarcated red lesions. Three of the eight lesions (37.5 %) detected by WLE were confirmed later as ESCNs. There was no advanced esophageal squamous cell carcinoma detected in any patient.

In total, 21 Lugol's voiding lesions larger than 5 mm were detected in 12 patients (27 %), 11 of whom were male (92 %). The index head and neck cancers were hypopharynx (n = 3), oral cavity (n = 3), glottis (n = 3), oropharynx (n = 2), and tonsil (n = 1). All of these patients were considered to be cured from the index cancer and had a regular follow-up before entering the present study. All of the positive lesions detected under WLE (n = 8) were also Lugol's voiding lesions. The size of the Lugol's voiding lesions ranged from 5 mm to 26 mm (mean 10 mm, SD 5.7 mm), and were located 15 -- 36 cm from the incisor (mean 27 cm, SD 5.1 cm). The histological results for these Lugol's voiding lesions are shown in [Table 3](#TB167-3){ref-type="table"}. There were seven ESCNs consisting of four high grade intraepithelial neoplasias and three low grade intraepithelial neoplasias ([Fig. 4](#FI167-4){ref-type="fig"}). The specificity of the diagnosis for ESCN by Lugol's spray technique was only 33 %. There were 14 non-neoplastic lesions consisting of active esophagitis (n = 6), glycogenation with inflammation (n = 3), acute ulcer (n = 1), inlet patch (n = 1), and unremarkable changes (n = 3) ([Fig. 4](#FI167-4){ref-type="fig"}). \[Generally, lesions with glycogenation should appear very dark on Lugol's staining and we did not mention this in the results as we excluded those lesions from our study. However, there were certain lesions that had a combination of inflammation and glycogenation and part of the lesion presented as Lugol's voiding. This in turn leads to Lugol's voiding glycogenation.\]

###### Histological results for Lugol's voiding lesions (n = 21).

  Histological results                             Number of lesions (%)
  ------------------------------------------------ -----------------------
  High grade intraepithelial neoplasia/carcinoma   4 (19)
  Low grade intraepithelial neoplasia              3 (14)
  Active esophagitis                               6 (29)
  Inlet patch                                      1 (5)
  Glycogenation with inflammation                  3 (14)
  Unremarkable change                              3 (14)
  Acute ulcer                                      1 (5)

Seven ESCNs were detected in four out of the 44 patients (9 % of all screened patients), whose ages ranged from 59 to 66 years. Three of these patients were male. The index head and neck cancers were hypopharynx, oropharynx, oral cavity, and glottis. Two patients had a single lesion, one had two lesions, and another had three lesions. The mean time to diagnose of ESCN was 26 months (18 -- 42 months) after the diagnosis of index head and neck cancer, while the mean interval between endoscopy and the diagnosis of index head and neck cancer in patients without ESCN was 28 months (5 -- 117 months). The size of the lesions ranged from 5 mm to 26 mm (mean 14 mm) and were located 25 -- 36 cm (mean 30 cm) from the incisor. By using histology as the gold standard, the sensitivity, specificity, PPV, NPV, and accuracy of dNBI were 85 %, 62 %, 54 %, 89 %, and 70 %, respectively, while those of pCLE were 83 %, 92 %, 83 %, 92 %, and 89 %, respectively, as shown in [Table 4](#TB167-4){ref-type="table"}. The treatment for the two patients with a single lesion of ESCN was endoscopic mucosal resection, and the treatment for the two patients with synchronous lesions was surgical resection.

###### Performance of pCLE and dNBI for ESCN detection in esophageal Lugol's voiding lesions.

                            pCLE            dNBI
  ------------------------- --------------- ---------------
  Sensitivity (95 %CI), %   83 (44 -- 97)   85 (49 -- 97)
  Specificity (95 %CI), %   92 (65 -- 99)   62 (35 -- 82)
  PPV (95 %CI), %           83 (44 -- 97)   54 (28 -- 79)
  NPV (95 %CI), %           92 (65 -- 99)   89 (57 -- 98)
  Accuracy (95 %CI), %      89 (67 -- 97)   70 (48 -- 85)

CI, confidence interval; pCLE, probe-based confocal laser endomicroscopy; dNBI, dual focus narrow-band imaging; NVP, negative predictive value; PPV, positive predictive value; ESCN, early esophageal squamous cell neoplasm.All *P* values \> 0.05.

Discussion
==========

Symptomatic esophageal cancer patients carry a dismal prognosis when they are diagnosed at later stages [@JR167-2]. Therefore, it is important to have a surveillance protocol for ESCN patients while they are still asymptomatic. The best target population to undergo a surveillance protocol is patients with previous head and neck cancer. Our study population included asymptomatic patients with a previous history of head and neck cancer. By excluding patients with squamous cell cancer of the nasopharynx from our target surveillance, we found the incidence rate of ESCNs to be 9 %, which was relatively lower than the incidence rate reported by Priante et al. [@JR167-1]. In their study, they reported an incidence rate of a second primary esophageal cancer in the range from 9 % to 44 %. The explanation for the higher incidence in other studies is that they also recruited cases with symptomatic esophageal cancer [@JR167-1] [@JR167-8] [@JR167-20]. In keeping with the previous report, the mean interval after diagnosis of index head and neck cancer in our series was not different from the series reported by Schwartz et al. [@JR167-10] (26 months, range 18 -- 42 months).

This study confirms the suboptimal detection rate for ESCNs by standard WLE, as WLE detected only three of seven ESCNs (43 %). The sensitivity of WLE in our study was comparable to that in previous studies, which was reported to be 55 -- 66 % [@JR167-20] [@JR167-27]. Although Lugol's spray has been promoted as a technique to improve the sensitivity for ESCN detection, the specificity of Lugol's chromoendoscopy for the diagnosis of esophageal squamous neoplasms was previously reported to be suboptimal at 63 -- 85 % as non-neoplastic lesions were also diagnosed as Lugol's voiding lesions [@JR167-18] [@JR167-19] [@JR167-21] [@JR167-28]. We proposed that real-time endoscopy could be an adjunctive method that may improve the specificity for predicting the pathology of Lugol's voiding lesions. Currently, there are many available techniques, such as magnifying digital chromoendoscopy (NBI, Fujinon intelligent chromoendoscopy (FICE), and the Pentax i-SCAN system), confocal laser endomicroscopy, and endocytoscopy. The advantages of these endoscopic modalities over WLE are the ability to magnify and depict the early neoplasm, to portray the cells and their pattern, to detect the abnormal structure of neoplastic capillaries, and to detect early vascular leakage from abnormal capillaries. In this study, we directly compared the diagnostic capability of pCLE and dNBI in Lugol's voiding lesions. In our study, only one-third of Lugol's voiding lesions larger than 5 mm were ESCNs. Many Lugol's voiding lesions in this study were active esophagitis and unremarkable changes that could have resulted from the radiation therapy [@JR167-29], resulting in the lower specificity of Lugol's evaluation. This issue addresses the necessity to characterize Lugol's voiding lesions in order to avoid unnecessary biopsies. The abnormal vascular pattern studied by dNBI and pCLE can help distinguish neoplastic from inflammatory lesions. Moreover, the cellular features can also be additionally studied by pCLE. However, some cardinal features, such as identification of the inflammatory cells in esophagitis and evaluation of the nuclear-cytoplasmic ratio, nuclear pleomorphism, and hyperchromatism in order to determine the degree of dysplasia in neoplastic lesions, cannot be appreciated by the current model of pCLE.

The sensitivity, specificity, and accuracy of pCLE in our series using cellular and vascular criteria to predict ESCN were 83 %, 92 % and 89 %, respectively. The study by Pech et al. [@JR167-25], which investigated 43 Lugol's voiding lesions larger than 5 mm in 21 patients using eCLE, yielded sensitivity, specificity, and accuracy of 100 %, 87 %, and 95 %, respectively. Although the results from the two studies were comparable, we believe that it might have been more challenging to detect ESCN in our study because our patients were all asymptomatic and had not been subjected to endoscopy previously, whereas the patients in the previous study [@JR167-25] were already suspected of having ESCN from endoscopy performed before beginning the new study.

The sensitivity of dNBI in this study, using the criteria of two or more abnormal IPCL patterns (corresponding to Inoue's classification type IV), is comparable to that of previous studies (85 % vs. 91 -- 100 %), but, unfortunately, the specificity and accuracy are lower (62 % vs. 80 -- 95 % and 70 % vs. 95 %, respectively) [@JR167-20] [@JR167-21]. Although the differences were not statistically significant, we found a trend of lower specificity, PPV, and accuracy of dNBI than for pCLE to diagnose ESCN. We speculate that the lower specificity, PPV, and accuracy of dNBI in this study were possibly because of the interference from Lugol's stain on the interpretation of IPCL. Another disadvantage of dNBI compared with pCLE is its inability to read cellular morphology such as the abnormal squamous cells because its magnification (75 ×) is not sufficiently high to evaluate the structure of cells. In our opinion, the combination of abnormal cellular and IPCL patterns is very helpful in diagnosing ESCN, and pCLE better serves this purpose.

Our study has several limitations. First, this was a pilot test on pCLE for ESCN detection as there were only scarce data available for this modality. Although, we applied the same criteria based on a previous study using eCLE, in pCLE with its fixed and narrower level of scanning depth when compared with eCLE, it was possible that the sensitivity to detect ESCN by pCLE would be lower. Second, our sample size was small, as patients with head and neck cancer have poor survival and many were not eligible for the study because of our very strict inclusion criteria. Third, we did not randomly assign the order of dNBI and pCLE because pCLE application must be in direct contact with the lesion. This, in turn, may alter the IPCL pattern, which would be read by the subsequent dNBI. Therefore, we always had to begin our study with dNBI followed by pCLE. However, to prevent an interpretation bias, the second endoscopist performing the pCLE examination was never told about the earlier dNBI results. Fourth, as mentioned earlier, the Lugol's voiding lesions were sometimes not completely washed out before dNBI examination. Despite using a low concentration of Lugol's solution (0.5 %) and with vigorous irrigation with normal saline before dNBI examination, Lugol's iodine significantly influenced the observation of IPCL structure which led to suboptimal dNBI function. Thus, this study could not be presented as advancing the field especially in NBI outcome. Although, the literature had shown that a pink color sign, which was a completely unstained area after the brown color of iodine solution had faded, was highly specific for diagnosing high grade dysplasia and squamous cell carcinoma [@JR167-30]. Unfortunately, in our study, we did not observe pink color in any high grade intraepithelial neoplasia (n = 4) and we did not have any intramucosal cancer. Perhaps the number of positive cases might be too low to discover this phenomenon. Fortunately, we observed that the pCLE evaluation was not affected by the remnant Lugol's stain. Finally, this study was not designed to calculate the cost effectiveness of the additional procedures that require sophisticated devices such as dNBI and pCLE. At the time of this study in Thailand, this technique, in particular pCLE, was more expensive to perform than a routine biopsy with pathological analysis (300 USD vs. 40 USD) and took longer procedural time than a routine biopsy (40 minutes vs. 15 minutes). However, we envisage that, as the technology progresses and with increased experience of the operator, in time, the cost of pCLE and duration of the procedure may be justified for routine practice. Therefore, a future study, which directly addresses this issue by calculating the number of patients with a previous history of head and neck cancer to be screened for one positive ESCN, is necessary before implementing this protocol into real practice.

Without prior Lugol's spray and the pCLE examination, we propose that dNBI can be useful as the primary modality to detect and characterize suspected ESCN lesions. However, Lugol's chromoendoscopy still provides higher sensitivity than that of the NBI examination and is considered to be the gold standard in ESCN detection [@JR167-20] [@JR167-21] [@JR167-22] [@JR167-28] [@JR167-31]. Takenaka et al. [@JR167-21] reported the usefulness of Lugol's chromoendoscopy to detect additional low grade and high grade intraepithelial neoplasias (ESCN) after NBI examination. They demonstrated that the overall sensitivity of Lugol's chromoendoscopy vs. NBI examination to detect esophageal squamous cell carcinoma, including ESCN, was 100 % vs. 91 % [@JR167-21]. In our opinion, Lugol's spray can be subsequently added to detect the NBI-negative ESCNs. However, these additional lesions should be further studied by confocal laser examination to minimize the number of unnecessary biopsies. In contrast, if there are no additional lesions detected by Lugol's chromoendoscopy, the pCLE examination can be omitted.

In conclusion, pCLE provides a trend of higher specificity and accuracy than dNBI to differentiate between neoplastic and non-neoplastic lesions in Lugol's voiding lesions in patients with a history of head and neck cancer. As a result of the incomplete wash out of Lugol's spray, the performance of dNBI for the examination of a capillary network in this situation is suboptimal. Future study is needed to seek a significant difference in the performance between dNBI and pCLE in a larger population.
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